Molecular and cellular aspects of the impact of secondary metabolites from common barberry and hybrid goat’s rue on the HeLa cell line
https://doi.org/10.17709/2410-1893-2023-10-4-3
EDN: WNOCXO
Abstract
Purpose of the study. To isolate and verify pure fractions of secondary plant metabolites contained in B. vulgaris (L.) and P. hibridus (L.), as well as to conduct a model experiment and molecular genetic study to evaluate their cytotoxic effect in vitro on the HeLa cell line.
Materials and methods. The isolation and verification of all compounds used in the experiment were carried out using column chromatography and nuclear magnetic resonance methods at the Department of Natural Compounds, Faculty of Chemistry, Southern Federal University. Subsequently, an experiment was conducted using cultural and molecular methods on the HeLa cell line in three repetitions for each test compound; after incubation with them, the numbers of dead cells were counted on the automated NanoEnTek JuliFl counter, and the numbers of cells in apoptosis were measured by flow cytometry on the BD analyzer FACS Canto II. The level of copy number variation and expression of genes responsible for apoptosis were assessed by real-time PCR (RT-PCR). In total, three substances were studied, with two concentrations (4 and 12 μg/ml) and two exposures (24 and 72 hours) for each of them.
Results. In the first stage of the study, we isolated and verified the berberine alkaloid extracted from the roots of B. vulgaris (L.), as well as 2,4-dihydroxy-2,5-dimethylfuran-3(2H)-one and 2,2,8-trimethyldecahydroazulene-5,6-dicarbaldehyde from P. hibridus (L.). The subsequent stage of the study demonstrated the maximal cellular death under the action of berberine at a 72-hour exposure. However, the RT-PCR assessment of the copy number variation and expression of the CASP8, CASP9, CASP3, BAX, BCL2, TP53 and MDM2 genes revealed the presence of apoptosis initiation in tumor cells at the molecular level under the action of all the studied compounds: both berberine and furan and azulene derivatives derived from P. hibridus (L.).
Conclusion. All compounds used in the experiment exhibited a cytotoxic effect on the HeLa cell line. Berberine alkaloid showed the most pronounced cytotoxic effect on the HeLa line as recorded by all methods used in the study. Terpenoids 4-dihydroxy-2,5-dimethylfuran-3(2H)-one and 2,2,8-trimethyldecahydroazulene-5,6-dicarbaldehyde, when exposed to the HeLa line, caused an increase in the copy number variation and expression of the CASP9, CASP3 loci, which are among the main activators of apoptosis. They also influenced the expression of TP53 and MDM2 loci.
About the Authors
E. Yu. Zlatnik
Rostov-on-Don, Russian Federation
Elena Yu. Zlatnik – Dr. Sci. (Medicine), Professor, Chief Researcher, Laboratory of Immunophenotyping of Tumors, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-1410-122X, SPIN: 4137-7410, AuthorID: 327457, Scopus Author ID: 6603160432
Competing Interests:
Author state that there are no conflicts of interest to disclose.
Ya. S. Enin
Rostov-on-Don, Russian Federation
Yaroslav S. Enin – Junior Researcher, Laboratory of Molecular Oncology, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-4572-1579, SPIN: 7683-2286, AuthorID: 840050, Scopus Author ID: 57196464479
Competing Interests:
Author state that there are no conflicts of interest to disclose.
O. N. Burov
Rostov-on-Don, Russian Federation
Oleg N. Burov – Cand. Sci. (Chemistry), Associate Professor, Department of Natural and High Molecular Compounds, Faculty of Chemistry, Southern Federal University, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-7704-033X, SPIN: 5269-7656, AuthorID: 642948, Scopus Author ID: 23033004000, ResearcherID: A-8428-2014
Competing Interests:
Author state that there are no conflicts of interest to disclose.
E. S. Bondarenko
Rostov-on-Don, Russian Federation
Elena S. Bondarenko – Junior Researcher, Laboratory of Immunophenotyping of Tumors, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-8522-1026, SPIN: 3117-4040, Author ID: 865798, Scopus Author ID: 57200132337
Competing Interests:
Author state that there are no conflicts of interest to disclose.
A. B. Sagakyants
Rostov-on-Don, Russian Federation
Alexander B. Sagakyants – Cand. Sci. (Biology), Head of the Laboratory of Immunophenotyping of Tumors, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0003-0874-5261, SPIN: 7272-1408, AuthorID: 426904, Scopus Author ID: 24329773900, ResearcherID: U-5422-2017
Competing Interests:
Author state that there are no conflicts of interest to disclose.
D. S. Kutilin
Rostov-on-Don, Russian Federation
Denis S. Kutilin – Cand. Sci. (Biology), Leading Researcher, Laboratory of Molecular Oncology, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-8942-3733, SPIN: 8382-4460, AuthorID: 794680, Scopus Author ID: 55328886800
Competing Interests:
Author state that there are no conflicts of interest to disclose.
Yu. V. Dzigunova
Rostov-on-Don, Russian Federation
Yulia V. Dzigunova – Senior Lecturer in the Department of Botany at the Academy of Biology and Biotechnology named after D. I. Ivanovsky, Southern Federal University, Rostov-on-Don, Russian Federation SPIN: 2204-2967, AuthorID: 1062681
Competing Interests:
Author state that there are no conflicts of interest to disclose.
O. G. Ishonina
Rostov-on-Don, Russian Federation
Olga G. Ishonina – Cand. Sci. (Biology), Head of the Department of Training and Retraining of Specialists, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-5300-1213, SPIN: 4051-5165, AuthorID: 612417, Scopus Autor ID: 37115461900
Competing Interests:
Author state that there are no conflicts of interest to disclose.
E. V. Shalashnaya
Rostov-on-Don, Russian Federation
Elena V. Shalashnaya – Cand. Sci. (Biology), Senior Researcher, Laboratory for the Study of the Pathogenesis of Malignant Tumors, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0001-7742-4918, SPIN: 2752-0907, AuthorID: 476968, Scopus Autor ID: 55144159900, ResearcherID: AAE-4085-2022
Competing Interests:
Author state that there are no conflicts of interest to disclose.
N. D. Ushakova
Rostov-on-Don, Russian Federation
Nataliya D. Ushakova – Dr. Sci. (Medicine), Professor, anesthesiologist-resuscitator, Department of Anesthesiology and Intensive Care, National Medical Research Centre for Oncology of the Ministry of Health of Russia, Rostov-on-Don, Russian Federation ORCID: https://orcid.org/0000-0002-0068-0881, SPIN: 9715-2250, AuthorID: 571594, Scopus Author ID: 8210961900
Competing Interests:
Author state that there are no conflicts of interest to disclose.
References
1. Rosato I, Dalla Zuanna T, Tricarico V, Barbiellini Amidei C, Canova C. Adherence to cervical cancer screening programs in migrant populations: A systematic review and meta-analysis. Int J Environ Res Public Health. 2023;20(3):2200. https://doi.org/10.3390/ijerph20032200
2. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. https://doi.org/10.3322/caac.21660
3. Gado F, Ferrario G, Della Vedova L, Zoanni B, Altomare A, Carini M, et al. Targeting Nrf2 and NF-κB signaling pathways in cancer prevention: The role of apple phytochemicals. Molecules. 2023;28(3):1356. https://doi.org/10.3390/molecules28031356
4. Alves-Silva JM, Romane A, Efferth T, Salgueiro L. North African Medicinal Plants Traditionally Used in Cancer Therapy. Front Pharmacol. 2017 Jun 26;8:383. https://doi.org/10.3389/fphar.2017.00383
5. Yan Z, Lai Z, Lin J. Anticancer properties of traditional Chinese medicine. Comb Chem High Throughput Screen. 2017;20(5):423– 429. https://doi.org/10.2174/1386207320666170116141818
6. Habli Z, Toumieh G, Fatfat M, Rahal ON, Gali-Muhtasib H. Emerging cytotoxic alkaloids in the battle against cancer: Overview of molecular mechanisms. Molecules. 2017;22(2):250. https://doi.org/10.3390/molecules22020250
7. Hsiao YT, Kuo CL, Chueh FS, Liu KC, Bau DT, Chung JG. Curcuminoids induce reactive oxygen species and autophagy to enhance apoptosis in human oral cancer cells. Am J Chin Med. 2018;46(5):1145–1168. https://doi.org/10.1142/s0192415x1850060x
8. Bernardini S, Tiezzi A, Laghezza Masci V, Ovidi E. Natural products for human health: A historical overview of the drug discovery approaches. Nat Prod Res. 2018;32(16):1926–1950. https://doi.org/10.1080/14786419.2017.1356838
9. Kulinowski Ł, Luca SV, Minceva M, Skalicka-Woźniak K. A review on the ethnobotany, phytochemistry, pharmacology and toxicology of butterbur species (Petasites L.). J Ethnopharmacol. 2022;293:115263. https://doi.org/10.1016/j.jep.2022.115263
10. Guo L, Li K, Cui ZW, Kang JS, Son BG, Choi YW. S-Petasin isolated from Petasites japonicus exerts anti-adipogenic activity in the 3T3-L1 cell line by inhibiting PPAR-γ pathway signaling. Food Funct. 2019;10(7):4396–4406. https://doi.org/10.1039/c9fo00549h
11. Wang ZH, Hsu HW, Chou JC, Yu CH, Bau DT, Wang GJ, et al. Cytotoxic effect of s-petasin and iso-s-petasin on the proliferation of human prostate cancer cells. Anticancer Res. 2015;35(1):191–199.
12. Guo L, Kang JS, Kang NJ, Choi YW. S-petasin induces apoptosis and inhibits cell migration through activation of p53 pathway signaling in melanoma B16F10 cells and A375 cells. Arch Biochem Biophys. 2020;692:108519. https://doi.org/10.1016/j.abb.2020.108519
13. Matsumoto T, Imahori D, Saito Y, Zhang W, Ohta T, Yoshida T, et al. Cytotoxic activities of sesquiterpenoids from the aerial parts of Petasites japonicus against cancer stem cells. J Nat Med. 2020;74(4):689–701. https://doi.org/10.1007/s11418-020-01420-x
14. Lu B, Hu M, Liu K, Peng J. Cytotoxicity of berberine on human cervical carcinoma HeLa cells through mitochondria, death receptor and MAPK pathways, and in-silico drug-target prediction. Toxicol In Vitro. 2010;24(6):1482–1490. https://doi.org/10.1016/j.tiv.2010.07.017
15. Zhu X, Yue H, Guo X, Yang J, Liu J, Liu J, Wang R, Zhu W. The Preconditioning of Berberine Suppresses Hydrogen Peroxide-Induced Premature Senescence via Regulation of Sirtuin 1. Oxid Med Cell Longev. 2017;2017:2391820. https://doi.org/10.1155/2017/2391820
16. Chuang TY, Wu HL, Min J, Diamond M, Azziz R, Chen YH. Berberine regulates the protein expression of multiple tumorigenesis-related genes in hepatocellular carcinoma cell lines. Cancer Cell Int. 2017 May 30;17:59. https://doi.org/10.1186/s12935-017-0429-3
17. Luo H, Vong CT, Chen H, Gao Y, Lyu P, Qiu L, et al. Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine. Chin Med. 2019;14:48. https://doi.org/10.1186/s13020-019-0270-9
18. Li J, Liu F, Jiang S, Liu J, Chen X, Zhang S, Zhao H. Berberine hydrochloride inhibits cell proliferation and promotes apoptosis of nonsmall cell lung cancer via the suppression of the MMP2 and Bcl-2/Bax signaling pathways. Oncol Lett. 2018 May;15(5):7409–7414. https://doi.org/10.3892/ol.2018.8249
19. Zhong XD, Chen LJ, Xu XY, Liu YJ, Tao F, Zhu MH, et al. Berberine as a potential agent for breast cancer therapy. Front Oncol. 2022;12:993775. https://doi.org/10.3389/fonc.2022.993775
20. Yao Z, Wan Y, Li B, Zhai C, Yao F, Kang Y, Liu Q, Lin D. Berberine induces mitochondrial mediated apoptosis and protective autophagy in human malignant pleural mesothelioma NCI H2452 cells. Oncol Rep. 2018 Dec;40(6):3603–3610. https://doi.org/10.3892/or.2018.6757
21. Rossberg M, Lendle W, Pfleiderer G, Togel A, Dreher EL, Langer E, et al. Chlorinated Hydrocarbons. Ullmann’s Encyclopedia of Industrial Chemistry. Weinheim: Wiley-VCH; 2006. https://doi.org/10.1002/14356007.a06_233
22. Kit OI, Filippova SYu, Timofeeva SV, Sitkovskaya AO, Zlatnik EYu, Kolpakov SA, et al. Influence of oncolytic strains of a new unclassified group of human rotaviruses on peripheral blood lymphocytes. South Russian Journal of Cancer. 2021;2(3):23–30. https://doi.org/10.37748/2686-9039-2021-2-3-3
23. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156–159. https://doi.org/10.1006/abio.1987.9999
24. Kutilin DS, Zinkovich MS, Gusareva MA, Faenson AV, Karnaukhova EA, Rozenko LY, et al. Gene copy number variation as a factor of radiation resistance of prostate tumor cells. Modern Problems of Science and Education. 2020;4:82. (In Russ.). https://doi.org/10.17513/spno.29866
25. Suzuki N, Johmura Y, Wang TW, Migita T, Wu W, Noguchi R, et al. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis. Autophagy. 2021;17(11):3776–3793. https://doi.org/10.1080/15548627.2021.1897961
26. Warowicka A, Nawrot R, Goździcka-Józefiak A. Antiviral activity of berberine. Arch Virol. 2020;165(9):1935–1945. https://doi.org/10.1007/s00705-020-04706-3
27. Zhang C, Sheng J, Li G, Zhao L, Wang Y, Yang W, et al. Effects of berberine and its derivatives on cancer: A systems pharmacology review. Front Pharmacol. 2020;10:1461. https://doi.org/10.3389/fphar.2019.01461
28. Liu D, Meng X, Wu D, Qiu Z, Luo H. A natural isoquinoline alkaloid with antitumor activity: Studies of the biological activities of berberine. Front Pharmacol. 2019;10:9. https://doi.org/10.3389/fphar.2019.00009
29. Suyatmi S, Mudigdo A, Purwanto B, Indarto D, Hakim FA, Krisnawati DI. Brazilin isolated from caesalpina sappan wood induces intrinsic apoptosis on A549 cancer cell line by increasing p53, caspase-9, and caspase-3. Asian Pac J Cancer Prev. 2022;23(4):1337– 1343. https://doi.org/10.31557/apjcp.2022.23.4.1337
30. Levine AJ. p53: 800 million years of evolution and 40 years of discovery. Nat Rev Cancer. 2020;20(8):471–480. https://doi.org/10.1038/s41568-020-0262-1
Supplementary files
Review
For citations:
Zlatnik E.Yu., Enin Ya.S., Burov O.N., Bondarenko E.S., Sagakyants A.B., Kutilin D.S., Dzigunova Yu.V., Ishonina O.G., Shalashnaya E.V., Ushakova N.D. Molecular and cellular aspects of the impact of secondary metabolites from common barberry and hybrid goat’s rue on the HeLa cell line. Research and Practical Medicine Journal. 2023;10(4):31-47. (In Russ.) https://doi.org/10.17709/2410-1893-2023-10-4-3. EDN: WNOCXO